Global Transthyretin Amyloidosis (ATTR) Epidemiology Forecast to 2027, Covering Markets Such as the U.S., Germany, Spain, Italy, France, U.K. & Japan - ResearchAndMarkets.com

DUBLIN--()--The "Transthyretin Amyloidosis (ATTR) - Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total diagnosed prevalent cases, type-specific diagnosed prevalent cases, treatable cases and Surgery Cases of ATTR related Carpal Tunnel Syndrome) scenario of Transthyretin Amyloidosis in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, the total diagnosed prevalent population of Transthyretin Amyloidosis (ATTR) was found to be 19,160 in the year 2016 in 7MM.

Report Scope:

  • The report covers detailed overview of Transthyretin Amyloidosis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Transthyretin Amyloidosis in 7 major markets covering the United States, EU5 & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by type i.e., Hereditary [FAP (FAP Stage 0, I,II,III) & FAC] and non-hereditary cases of ATTR in 7MM

Key assessments:

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered:

1. Key Insights

2. Disease Background and Overview: Transthyretin-related amyloidosis (ATTR)

3. Epidemiology and Patient Population

4. Country Wise-Epidemiology of Transthyretin Amyloidosis (ATTR)

5. Diagnosed Surgery Cases of ATTR related Carpal Tunnel Syndrome

6. Appendix

7. Capabilities

8. Disclaimer

9. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/research/w3flzh/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs, Endocrine and Metabolic Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs, Endocrine and Metabolic Disorders Drugs